Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SAfiledCriticalSynthelabo SA
Priority to FR9300339ApriorityCriticalpatent/FR2700547B1/fr
Publication of FR2700547A1publicationCriticalpatent/FR2700547A1/fr
Application grantedgrantedCritical
Publication of FR2700547B1publicationCriticalpatent/FR2700547B1/fr
C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
C07D517/04—Ortho-condensed systems
FR9300339A1993-01-151993-01-15Dérivés d'imidazo[2,1-b]benzosélénazole-3-acétamide, leur préparation et leur application en thérapeutique.
Expired - Fee RelatedFR2700547B1
(fr)